Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like AstraZeneca PLC Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More April 26, 2017 PharmaJet Releases Positive Phase I Results for Hantavirus Vaccines March 13, 2018 Ultrafast Detection Of A Cancer Biomarker Enabled By Innovative Nanobiodevice, Reveals March 7, 2017
AstraZeneca PLC Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More April 26, 2017